Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-28
2005-06-28
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253010, C544S384000, C544S363000
Reexamination Certificate
active
06911447
ABSTRACT:
Disclosed are MC-3/MC-4 receptor ligands, the ligands having the following formula:wherein A is a conformationally restricted ring system selected from the group consisting of:a) non-aromatic carbocyclic rings;b) aromatic carbocyclic rings;c) non-aromatic heterocyclic rings;d) aromatic heterocyclic rings;wherein said rings comprises from 5 to 8 atoms; and W is a unit which preferable comprises D-1-fluorophenyalanine, Y comprises a heteroatom, and Z comprises an aromatic carbocyclic ring. Also disclosed are pharmaceutical compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 receptors.
REFERENCES:
patent: 5492916 (1996-02-01), Morriello et al.
patent: 5494919 (1996-02-01), Morriello et al.
patent: 5536716 (1996-07-01), Chen et al.
patent: 5721250 (1998-02-01), Morriello et al.
patent: 5721251 (1998-02-01), Chen et al.
patent: 5783582 (1998-07-01), Guo et al.
patent: 5804578 (1998-09-01), Chakravarty et al.
patent: 5877182 (1999-03-01), Nargund et al.
patent: 5880125 (1999-03-01), Nargund
patent: 5936089 (1999-08-01), Carpino et al.
patent: 5965565 (1999-10-01), Chen et al.
patent: 6294534 (2001-09-01), Nargund et al.
patent: 6350760 (2002-02-01), Bakshi et al.
patent: WO 94/13696 (1994-06-01), None
patent: WO 94/19367 (1994-09-01), None
patent: WO 96/02530 (1996-02-01), None
patent: WO 96/13265 (1996-05-01), None
patent: WO 96/38471 (1996-12-01), None
patent: WO 98/10653 (1998-03-01), None
patent: WO 99/55679 (1999-11-01), None
patent: WO 99/58501 (1999-11-01), None
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/70337 (2001-09-01), None
patent: WO 01/70708 (2001-09-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 02/00654 (2002-01-01), None
patent: WO 02/15909 (2002-02-01), None
patent: WO 02/59107 (2002-08-01), None
patent: WO 02/59117 (2002-08-01), None
patent: WO 02/68387 (2002-09-01), None
patent: WO 02/68388 (2002-09-01), None
patent: WO 02/70511 (2002-09-01), None
patent: WO 03/031410 (2003-04-01), None
Fisher et al. Melanocortin-4 receptor: a novel signalling pathway involved in body wieght regulation, Int. J. Obes. Relat. Metab. 1999, Suppl 1:54-8 (Abstract).
Ebetino Frank Hallock
Hu Xiufeng Eric
Mazur Wieslaw Adam
Tian Xinrong
Echler Sr. Richard S.
Liu Hong
Raymond Richard L.
The Procter & Gamble & Company
LandOfFree
Melanocortin receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanocortin receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3488254